This inventor holds 1 USPTO granted patent. Top assignee: Ciba-Geigy Corporation. Active years: 1982.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1982
Title: The Innovative Contributions of Hans Hess
Introduction
Hans Hess is a notable inventor based in Binningen, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. His work focuses on creating formulations that enhance the efficacy and usability of medications.
Latest Patents
One of Hans Hess's key inventions is a patent for a divisible tablet that has controlled and delayed release of the active substance. This invention is designed to improve the administration of medications by allowing for a more precise release of active ingredients. The tablet is characterized by its oblong shape and specific dimensions, which facilitate its intended function. The design includes deep dividing grooves that ensure the tablet can be easily divided while maintaining its structural integrity.
Career Highlights
Hans Hess has been associated with Ciba-Geigy Corporation, a prominent player in the pharmaceutical industry. His work at the company has allowed him to explore innovative solutions in drug formulation and delivery. With a focus on enhancing patient outcomes, he has dedicated his career to advancing pharmaceutical technologies.
Collaborations
Throughout his career, Hans has collaborated with various professionals in the field, including his coworker Carlo Voellmy. These collaborations have fostered an environment of innovation and have contributed to the successful development of new pharmaceutical products.
Conclusion
Hans Hess's contributions to the field of pharmaceuticals, particularly through his patented divisible tablet, highlight his commitment to innovation in drug delivery systems. His work continues to influence the industry and improve patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile